Sulfasalazin-Heyl®

Active substance:

Sulfasalazine

ATC-Code :

M01CX02

Pharmaceutical form:

enteric coated tablet

Therapeutic indications:

Treatment of active rheumatoid arthritis (chronic polyarthritis) in adults
Treatment of active juvenile idiopathic oligoarthritis (enthesitis-associated arthritis) in children from the age of six, who responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs) and/or locale glucocorticoid injections
Treatment of active juvenile idiopathic polyarthritis and polyarthritic spondylarthritis in children from the age of six (enthesitis-associated arthritis), who responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs)

PDF-Download summary of product characteristics

11.05.2016 | Category: » Pharma

Wilson JP et al. 2015; Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic Acid (DTPA) formulation in beagle dogs; Health Phys. 108(3):308-18

Study design: Beagle dogs received various doses of NanoDTPATM capsules to decorporate administered 241Americium (241Am). Efficacy of NanoDTPATM was compared to intravenously … » More

11.05.2016 | Category: » Pharma

Shankar GN et al. 2014; Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats; Drug Dev. Res. 75(1):37-46

Study design: Beagle dogs were treated with increasing doses of trisodium zinc pentetate (Zn-DTPA) in a novel oral solid tablet form for seven days to determine its toxicity … » More

11.05.2016 | Category: » Vitamine

Schwartz JB et al. 2016; Response of vitamin D concentration to vitamin D₃ administration in older adults without sun exposure: A randomized double-blind trial; J. Am. Geriatr. Soc. 64(1):65-72

Study design: Randomized double-blind investigation to evaluate the 25 OHD levels in elderly nursing home residents after 16 weeks when 800, 2 000 or 4 000 IU/day or 50 000 … » More

11.05.2016 | Category: » Vitamine

Välimäki VV et al. 2016; How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? A placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D₃ every 3 months in elderly women; Clin. Endocrinol. 84(6):837-44

Study design: Elderly women received 100 000 or 200 000 IU of vitamin D3 or placebo orally every 3 months plus 1 g of calcium daily over one year to test intermittent … » More

HEYL

Chemisch-pharmazeutische Fabrik GmbH & Co. KG

Sulfasalazin-Heyl®

Login for medical expert groups

Please enter your Heyl password

Request login information